Home Cart Sign in  
Chemical Structure| 1030612-90-8 Chemical Structure| 1030612-90-8

Structure of MK-8245
CAS No.: 1030612-90-8

Chemical Structure| 1030612-90-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MK-8245 is a liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy.

Synonyms: MK-8245

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MK-8245

CAS No. :1030612-90-8
Formula : C17H16BrFN6O4
M.W : 467.25
SMILES Code : O=C(O)CN1N=C(C2=CC(N3CCC(OC4=CC(F)=CC=C4Br)CC3)=NO2)N=N1
Synonyms :
MK-8245
MDL No. :MFCD20039622
InChI Key :UJEAABFSXKCSGI-UHFFFAOYSA-N
Pubchem ID :24988881

Safety of MK-8245

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H332-H372-H400
Precautionary Statements:P260-P264-P270-P273-P280-P301+P312+P330-P304+P312-P305+P351+P338-P314-P337+P313-P391-P501
Class:9
UN#:3077
Packing Group:

Related Pathways of MK-8245

ferroptosis

Isoform Comparison

Biological Activity

Target
  • Dehydrogenase

    SCD1 (rat), IC50:3 nM

    SCD1 (mouse), IC50:1 nM

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Fed state on normal chow Oral 0.11, 0.33, 2, 10 mg/kg Single dose, study duration 4.5 hours Evaluate the inhibitory effect of MK-8245 on liver SCD1 activity, results showed MK-8245 significantly inhibited liver SCD1 activity, and the inhibition in plasma correlated with liver. PMC3137014

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.14mL

0.43mL

0.21mL

10.70mL

2.14mL

1.07mL

21.40mL

4.28mL

2.14mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories